Trovafloxacin-induced weakness due to a demyelinating polyneuropathy

Clinton K. Murray, Glenn W. Wortmann*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

9 Scopus citations


Fluoroquinolones have been associated with peripheral sensory disorders and weakness, especially in patients with underlying myasthenia gravis or myasthenia-like Eaton-Lambert syndrome. Trovafloxacin is a relatively new quinolone for which these side effects have not been described. We report a case of diffuse weakness due to a demyelinating polyneuropathy that began after initiation of trovafloxacin in a patient without an underlying neurologic disorder.

Original languageEnglish
Pages (from-to)514-515
Number of pages2
JournalSouthern Medical Journal
Issue number5
StatePublished - May 2000


Dive into the research topics of 'Trovafloxacin-induced weakness due to a demyelinating polyneuropathy'. Together they form a unique fingerprint.

Cite this